Success Stories: Our Team of Experts Helps an Indian Research Fellow in Biomedical Science Get EB1-A Approval in Less Than 2 Weeks with Premium Processing
Client’s Testimonial:
“Thanks so much once again. And, it was great working with you.”
On November 10th, 2021, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Fellow in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Research Fellow
Country of Origin: India
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: November 10th, 2021
Processing Time: 12 days (Premium Processing Requested)
Case Summary:
Our client from India is one of the few leading genetic disease experts in the field of biomedical science, and she has achieved a consistent and notable record of success and influence in this area of study. She is especially well-known for her work with epigenetics, aging, and age-related genetic diseases, such as cancer. This is why she could easily obtain 4 letters of support from experts in her field, 2 of who had the following to say of her work:
“[The client’s] research has illuminated the molecular causes of many of the challenges doctors face when treating brain cancers with contemporary immunotherapies. Additionally, her work has guided further research on strategic and targeted therapies for glioblastomas and other cancers. Because she has made such important findings related to cancer therapeutics, her research holds tremendous importance for people all around the world.”
“Through her work in biomedical science, [the client] analyzed age progression’s impact on DNA by manipulating key DNA repair factors. Her project proved that manipulating this process leads to less damage accumulation and more genomic stability, thus delaying and preventing age-related diseases, including cancer. Her research on this subject significantly benefits the United States, and she is more than worthy of the nation’s continued support.”
This is the reason that her work was funded by 3 institutions of national importance namely, the National Institutes of Health, the U.S. Department of Defense, and the Novartis Institutes for Biomedical Research.
On the other hand, she also has a brilliant record of publishing. Her work has been published as 12 journal articles and holds a massive record of citations at 1,140, making her in the top 1% of the most cited authors publishing in the field. She has also conducted reviews for some 30 different peers to date. These are the bits of information used by our expert to ensure beyond any doubt that our client had the extraordinary ability demanded by the USCIS for an EB1-A approval. We are glad to have been a part of her journey to success and we thank her for retaining us for her NIW petition which was also approved soon after.